<DOC>
	<DOCNO>NCT01133795</DOCNO>
	<brief_summary>The objective study evaluate effect administration midodrine albumin renal function patient cirrhosis creatinine great 1,2mg/dl .</brief_summary>
	<brief_title>Midodrine Albumin Cirrhotic Patients With Functional Renal Impairment</brief_title>
	<detailed_description>Twenty patient cirrhosis functional renal impairment , define serum creatinine great 1,2mg/dl , include . Patients receive daily midodrine dose 10mg tid 40g albumin 15-day interval . The follow-up period 12 week . In patient , liver renal function , vasoactive hormone ( plasma renin activity , aldosterone , noradrenaline , ADH , endothelin anf ) determine baseline condition . At moment , glomerular filtration rate renal plasma flow determine isotopic technique ambulatory blood pressure monitor 24-hour period perform . All determination repeat 4 12 week . During study period , albumin infusion , blood drawn creatinine electrolytes determination record well physical examination perform .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Midodrine</mesh_term>
	<criteria>Liver Cirrhosis Serum Creatinine great 1,2 mg/dL give write informed consent pregnancy Systolic blood pressure 150mmHg and/or diastolic blood pressure 90mmHg Previous treatment transjugular intrahepatic portosystemic shunt ( TIPS ) surgical shunt Antibiotic treatment previous 7 day inclusion , except prophylaxis spontaneous bacterial peritonitis infection HIV contraindication albumin and/or midodrine use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>cirrhosis</keyword>
	<keyword>renal failure</keyword>
	<keyword>hepatorenal syndrome</keyword>
	<keyword>albumine</keyword>
	<keyword>midodrine</keyword>
</DOC>